Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Arcturus Therapeutics Q1 EPS $(1.00) Beats $(1.19) Estimate, Sales $38.01M Beat $17.54M Estimate

Author: Benzinga Newsdesk | May 08, 2024 04:03pm
Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(1.00) per share which beat the analyst consensus estimate of $(1.19) by 15.97 percent. This is a 153.48 percent decrease over earnings of $1.87 per share from the same period last year. The company reported quarterly sales of $38.01 million which beat the analyst consensus estimate of $17.54 million by 116.72 percent. This is a 52.65 percent decrease over sales of $80.28 million the same period last year.

Posted In: ARCT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist